the southwest oncology group has carried out a phase i clinical trial of carboplatin plus cyclophosphamide and iproplatin plus cyclophosphamide in 20 patients with stages iii and iv ovarian cancer prior to initiating a phase iii trial to compare these platinum analog-cyclophosphamide combinations with standard cisplatin-cyclophosphamide therapy .
C0054403
carboplatin
C0010583
cyclophosphamide